If fewer than 2 AAbs are detected, additional screening may be appropriate for high-risk patients.2
If an OGTT is not available, an alternative method for diagnosing dysglycemia without overt hyperglycemia may be appropriate.1
Other methods that may be appropriate are available in the ADA and ISPAD guidelines.
Most common adverse reactions (>10%) were lymphopenia, rash, leukopenia, and headache.
Please see full Prescribing Information, including patient selection criteria, and Medication Guide.
View Important Safety Information page.